Barclays’s OKYO Pharma OKYO Stock Holding History

Barclays’s Portfolio OKYO Stock Details OKYO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-961,000	Closed	-$1.11M	–	5464
2024 Q4	$1.11M	Hold	961,000	–	–	﹤0.01%	3318
2024 Q3	$980K	Hold	961,000	–	–	﹤0.01%	3371
2024 Q2	$1.14M	Buy	961,000 +105,113	+12%	+$147K	﹤0.01%	2522
2024 Q1	$1.28M	Buy	855,887 +97,554	+13%	+$150K	﹤0.01%	2922
2023 Q4	$1.34M	Buy	758,333 +733,333	+2,933%	+$1.29M	﹤0.01%	3221
2023 Q3	$46.3K	Buy	+25,000	New	+$42K	﹤0.01%	3905

Other funds holding OKYO

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Continuum Advisory Eagle, Idaho $1.04B AUM 21.13% 1-Year Est. Return

Barclays's OKYO Position: Q1 2025 in Review

Barclays sold out of OKYO Pharma (OKYO) in Q1 2025, closing a stake of 961,000 shares — an estimated $1.11M sold.

Barclays first reported a position in OKYO in Q3 2023 and held it in 6 quarters. The position peaked at $1.34M in Q4 2023. 7 funds tracked by Wall St. Rank hold OKYO as of Q1 2025.

Barclays reported no remaining OKYO Pharma position as of Q1 2025 after selling out during the quarter.
Barclays sold 961,000 OKYO Pharma shares in Q1 2025, an estimated $1.11M.
Barclays first reported a position in OKYO Pharma in Q3 2023 and held it in 6 quarters.
Barclays's OKYO Pharma position peaked at $1.34M in Q4 2023.
7 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.